Immunological studies in patients receiving Corynebacterium parvum (C.P.) as immunotherapy for acute myelogenous leukemia (AML).
D000328:Adult; D006801:Humans; D007167:Immunotherapy; D015470:Leukemia, Myeloid, Acute / Q000276:immunology* / Q000628:therapy; D007958:Leukocyte Count; D008214:Lymphocytes / Q000276:immunology; D011425:Propionibacterium acnes / Q000276:immunology*